Pathogenesis and Clinical Management of Uterine Serous Carcinoma

by Li Zhang, Suet Ying Kwan, Kwong Kwok Wong, Pamela T. Soliman, Karen H. Lu, Samuel C. Mok
Published 2020-03-01

Metastatic serous endometrial carcinoma to the ureter

by Jessa W. Sahl, Andrew G. Bachman, Ga Hie Nam, Molly A. Brewer, Benjamin T. Ristau
Published 2021-11-01

A 4-gene signature predicts prognosis of uterine serous carcinoma

by Hui Chen, Lingjun Li, Ping Qin, Hanzhen Xiong, Ruichao Chen, Minfen Zhang, Qingping Jiang
Published 2021-02-01

Abdominopelvic Metastasis of Endometrial Serous Carcinoma Initially Misdiagnosed as Early-Stage Low-Grade Endometrioid Carcinoma: The Importance of Recognizing Minimal Uterine Sero...

by Jiheun Han, Hyun-Soo Kim
Published 2020-12-01

Recurrent uterine serous carcinoma with a germline pathogenic BRCA2 variant treated using olaparib: A case report

by Kayo Inoue, Hiroshi Tsubamoto, Tomoko Ueda, Chihiro Tajima, Nami Nakagomi
Published 2020-05-01

Regression of metastatic, radiation/chemotherapy-resistant uterine serous carcinoma overexpressing HER2/neu with trastuzumab emtansine (TDM-1)

by Alessandro D. Santin, Stefania Bellone, Natalia Buza, Peter E. Schwartz
Published 2017-02-01

Improved survival of patients with hypermutation in uterine serous carcinoma

by Alessandro D. Santin, Stefania Bellone, Floriana Centritto, Joseph Schlessinger, Richard Lifton
Published 2015-04-01

Clinicopathological and survival analysis of uterine papillary serous carcinoma: a single institutional review of 106 cases

by Wang Y, Yu M, Yang JX, Cao DY, Shen K, Lang JH
Published 2018-10-01

Concomitant diagnosis of endometrial and breast cancer - does the sequence matters?

by Tomer Stern, Shira Peleg Hasson, Akram Saad, Keren Levanon, Nadav Michaan, Ido Laskov, Ido Wolf, Tamar Safra
Published 2021-11-01

Selection of HER2/NEU negative tumor cells as a mechanism of resistance to trastuzumab in uterine serous carcinoma

by Silvia Pelligra, Natalia Buza, Pei Hui, Stefania Bellone, Burak Zeybek, Elena Ratner, Peter E. Schwartz, Giovanni Scambia, Alessandro D. Santin
Published 2020-05-01

Ubiquitin Carboxyl-Terminal Hydrolase L1 (UCHL1) Promotes Uterine Serous Cancer Cell Proliferation and Cell Cycle Progression

by Suet-Ying Kwan, Chi-Lam Au-Yeung, Tsz-Lun Yeung, Angela Rynne-Vidal, Kwong-Kwok Wong, John I. Risinger, Hui-Kuan Lin, Rosemarie E. Schmandt, Melinda S. Yates, Samuel C. Mok, Karen H. Lu
Published 2020-01-01

Impact of positive cytology in uterine serous carcinoma: A reassessment

by Logan Corey, Juliana Fucinari, Mohamed Elshaikh, Daniel Schultz, Rami Mussallam, Feras Zaiem, Fayez Daaboul, Omar Fehmi, Greg Dyson, Julie Ruterbusch, Robert Morris, Michelle L. Cote, Rouba Ali-Fehmi, Sudeshna Bandyopadhyay
Published 2021-08-01

Utility of a custom designed next generation DNA sequencing gene panel to molecularly classify endometrial cancers according to The Cancer Genome Atlas subgroups

by Eirwen M. Miller, Nicole E. Patterson, Gregory M. Gressel, Rouzan G. Karabakhtsian, Michal Bejerano-Sagie, Nivedita Ravi, Alexander Maslov, Wilber Quispe-Tintaya, Tao Wang, Juan Lin, Harriet O. Smith, Gary L. Goldberg, Dennis Y. S. Kuo, Cristina Montagna
Published 2020-11-01

Phosphorylation of STAT1 Serine 727 Enhances Platinum Resistance in Uterine Serous Carcinoma

by Zeng, Xiang
Published 2020

High expression of the p53 isoform γ is associated with reduced progression-free survival in uterine serous carcinoma

by Katharina Bischof, Stian Knappskog, Ingunn Stefansson, Emmet Martin McCormack, Jone Trovik, Henrica Maria Johanna Werner, Kathrine Woie, Bjorn Tore Gjertsen, Line Bjorge
Published 2018-06-01